Home
>
National Drug Code (NDC)
>
Pristiq
Pristiq - 0008-1222-01 - (DESVENLAFAXINE SUCCINATE)
Drug Information of Pristiq
| Product NDC: | 0008-1222 |
| Proprietary Name: | Pristiq |
| Non Proprietary Name: | DESVENLAFAXINE SUCCINATE |
| Active Ingredient(s): | 100 mg/1 & nbsp; DESVENLAFAXINE SUCCINATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pristiq
| Product NDC: | 0008-1222 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021992 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080501 |
Package Information of Pristiq
| Package NDC: | 0008-1222-01 |
| Package Description: | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01) |
NDC Information of Pristiq
| NDC Code | 0008-1222-01 |
| Proprietary Name | Pristiq |
| Package Description | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01) |
| Product NDC | 0008-1222 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DESVENLAFAXINE SUCCINATE |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080501 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | DESVENLAFAXINE SUCCINATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
